Rubius Therapeutics Inc (OTC Pink - Current Information:RUBY)
| 0.0158 Delayed Data As of Mar 22 |  -0.0042 / -21.00%Today’s Change | 0.02 Today|||52-Week Range 6.18 | -90.97% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | -- | |||
| Operating Activities | Net Income / Starting Line | -11.0M | -43.8M | -89.2M | -- | |
| Depreciation | 118.0K | 447.0K | 1.3M | -- | ||
| Total Other Cash Flow | 257.0K | 18.7M | 29.5M | -- | ||
| Funds From Operations | -10.6M | -24.7M | -58.5M | -- | ||
| Funds From/For Other Operating Expenses | -1.1M | -2.7M | -119.0K | -- | ||
| Net Cash Flow - Operating Activities | -9.5M | -21.9M | -58.3M | -- | ||
| Investing | Increase In Investments | 0.00 | 0.00 | -161.0M | -- | |
| Decrease In Investments | 0.00 | 0.00 | 64.3M | -- | ||
| Capital Expenditures | -443.0K | -2.3M | -15.0M | -- | ||
| Net Cash Flow Investing | -443.0K | -2.3M | -111.6M | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | -- | -- |
| Long Term Borrowings | 4.0M | 1.5M | 25.0M | -- | ||
| Long Term Debt Reduction | 0.00 | 0.00 | -5.5M | -- | ||
| Net Proceeds Stock Sale | 11.4M | 120.2M | 355.4M | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | -- | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | -- | -- | |
| Net Cash Flow - Financing | 15.4M | 121.7M | 374.8M | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 5.5M | 97.5M | 204.8M | -- | ||
